Budúce P/E spoločnosti 10x Genomics
Aká je hodnota metriky Budúce P/E spoločnosti 10x Genomics?
Hodnota metriky Budúce P/E spoločnosti 10x Genomics, Inc. je 196.08
Aká je definícia metriky Budúce P/E?
Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Budúce P/E spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou 10x Genomics
Čomu sa venuje spoločnosť 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Firmy s metrikou budúce p/e podobnou spoločnosti 10x Genomics
- Hodnota metriky Budúce P/E spoločnosti Bajaj Finserv je 182.01
- Hodnota metriky Budúce P/E spoločnosti Alibaba Health Information Technology je 185.19
- Hodnota metriky Budúce P/E spoločnosti MakeMyTrip Ltd je 187.87
- Hodnota metriky Budúce P/E spoločnosti Alibaba Health Information Technology je 188.68
- Hodnota metriky Budúce P/E spoločnosti Medexus Pharmaceuticals Inc je 188.68
- Hodnota metriky Budúce P/E spoločnosti Wynn Macau je 188.68
- Hodnota metriky Budúce P/E spoločnosti 10x Genomics je 196.08
- Hodnota metriky Budúce P/E spoločnosti Brooks Automation je 197.84
- Hodnota metriky Budúce P/E spoločnosti Dropsuite je 200.00
- Hodnota metriky Budúce P/E spoločnosti Medexus Pharmaceuticals je 200.00
- Hodnota metriky Budúce P/E spoločnosti Doximity je 200.00
- Hodnota metriky Budúce P/E spoločnosti CRH Medical je 200.00
- Hodnota metriky Budúce P/E spoločnosti Horizon Discovery plc je 200.00